Navigation Sciences, Inc.
Developer of an intraoperative image-guided surgical system that provides real-time, in‑vivo measurement of tumor margins to support tissue‑conserving resections for early‑stage lung and other soft‑tissue cancers. The technology integrates fiducial localization, instrument tracking, sensor‑fusion software and augmented reality visualization. The company has completed a 25‑patient clinical feasibility study under an FDA IDE, has an active patent portfolio and is pursuing regulatory clearance, reimbursement coding and continued product development including bronchoscopic marker deployment.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Products
Real-time surgical margin measurement system
A system combining an active tissue-adjacent fiducial marker, tracked surgical instruments, and software that provides AR visualization and numerical margin measurements to guide tissue‑conserving resections.
Real-time surgical margin measurement system
A system combining an active tissue-adjacent fiducial marker, tracked surgical instruments, and software that provides AR visualization and numerical margin measurements to guide tissue‑conserving resections.
Services
Conduct of investigator‑led prospective feasibility studies under IDE to evaluate safety and performance of intraoperative navigation and margin measurement.
Conduct of investigator‑led prospective feasibility studies under IDE to evaluate safety and performance of intraoperative navigation and margin measurement.
Expertise Areas
- Image-guided surgical navigation
- Clinical trial design and execution for medical devices
- Intraoperative margin assessment and validation
- Medical device research and prototype development
Key Technologies
- Augmented reality for surgical guidance
- Real-time sensor fusion and instrument tracking
- Fiducial marker localization
- Bronchoscopic/endoscopic marker deployment
News & Updates
Named a candidate for the 2025 Best Start-up award by the Galien Foundation.
Publication reporting results from a pilot clinical trial evaluating real-time intraoperative margin assessment during VATS.
White paper describing clinical rationale for intraoperative margin measurement and tissue‑conserving resections.
Awarded $400,000 STTR/SBIR grants to support development of bronchoscopic marker deployment and a software system for accurate deployment guidance.
Issued patents in the U.S., Europe and Japan covering core technologies for localization, margin measurement, deformation compensation and bronchoscopic delivery.
Named a candidate for the 2025 Best Start-up award by the Galien Foundation.
Publication reporting results from a pilot clinical trial evaluating real-time intraoperative margin assessment during VATS.
White paper describing clinical rationale for intraoperative margin measurement and tissue‑conserving resections.
Awarded $400,000 STTR/SBIR grants to support development of bronchoscopic marker deployment and a software system for accurate deployment guidance.
Issued patents in the U.S., Europe and Japan covering core technologies for localization, margin measurement, deformation compensation and bronchoscopic delivery.